-
Comprehensive Corporate and Securities Experience
Tony has more than 25 years of experience representing clients in a broad range of corporate and securities matters including IPOs and other public offerings, corporate governance, M&A transactions, strategic alliances, venture financings, and other transactional matters.
-
Represents Innovative Technology and Life Sciences Companies
Tony represents innovative technology and life sciences clients in a variety of sectors.
-
Recognized as a Leading Corporate Attorney
Tony was named in the 2018-2026 editions of Chambers USA: America's Leading Lawyers for Business and the 2020-2026 editions of Chambers Global.
-
Thought Leadership
Tony has been quoted in numerous articles about IPOs and other corporate transactional mattters in business and legal industry media, including Dow Jones/The Wall Street Journal, The Silicon Valley Business Journal, Law360, The Recorder, and The Daily Journal.
Tony Jeffries is chair of Wilson Sonsini Goodrich & Rosati’s board of directors and a partner at the firm, where his practice focuses on corporate, securities, governance, and related matters for technology and life sciences companies.
With more than 25 years of experience practicing corporate and securities law, Tony has represented clients ranging from entrepreneurs to Fortune 500 companies on IPOs and other public offerings, corporate governance, mergers and acquisitions, strategic alliances, venture capital financings, the structuring of start-up companies, and other transactional matters.
Among the clients Tony represents are companies in a wide variety of technology and life sciences sectors. He also represents prominent venture capital firms and investment banks.
Tony is a member of the Board of Visitors at Duke University School of Law.
Tony Jeffries is chair of Wilson Sonsini Goodrich & Rosati’s board of directors and a partner at the firm, where his practice focuses on corporate, securities, governance, and related matters for technology and life sciences companies.
With more than 25 years of experience practicing corporate and securities law, Tony has represented clients ranging from entrepreneurs to Fortune 500 companies on IPOs and other public offerings, corporate governance, mergers and acquisitions, strategic alliances, venture capital financings, the structuring of start-up companies, and other transactional matters.
Among the clients Tony represents are companies in a wide variety of technology and life sciences sectors. He also represents prominent venture capital firms and investment banks.
Tony is a member of the Board of Visitors at Duke University School of Law.
- J.D., Duke University School of Law, 1992With High Honors
- B.S., Finance, University of Colorado, Boulder, 1989Cum Laude
- Named in the 2020-2026 editions of Chambers Global, where he is described as “very thoughtful, collaborative and results-oriented”
- Named in the 2018-2026 editions of Chambers USA: America's Leading Lawyers for Business, where one source noted he is a “great partner who has got a really great practice,” while another stated he is “not only a supremely talented lawyer, but possesses great practical insights informed by extensive experience”
- State Bar of California
- State Bar of Colorado
- J.D., Duke University School of Law, 1992With High Honors
- B.S., Finance, University of Colorado, Boulder, 1989Cum Laude
- Named in the 2020-2026 editions of Chambers Global, where he is described as “very thoughtful, collaborative and results-oriented”
- Named in the 2018-2026 editions of Chambers USA: America's Leading Lawyers for Business, where one source noted he is a “great partner who has got a really great practice,” while another stated he is “not only a supremely talented lawyer, but possesses great practical insights informed by extensive experience”
- State Bar of California
- State Bar of Colorado
Select Recent IPOs
- HashiCorp (2021)
- Udemy (2021)
- KnowBe4 (2021)
- Impel NeuroPharma (2021 —Underwriters Counsel)
- Edgewise Therapeutics (2021)
- Seer (2020)
- Kinnate Biopharma (2020)
- ORIC Pharmaceuticals (2020)
- IGM Biosciences (2019)
- Peloton Therapeutics (2019—sold on eve of IPO)
- Allakos (2018)
- Dropbox (2018)
- Okta (2017—Underwriters Counsel)
- Denali Therapeutics (2017)
Select Public Clients
- Block (Square)
- Denali Therapeutics
- Edgewise Therapeutics
- Hawaiian Airlines
- IGM Biosciences
- Inspirato
- Kinnate Biopharma
- KnowBe4
- Seer
- Zymeworks
Select Private Clients
- Druva
- Enliven
- onX
- Plaid
- Pinger
Select Recent IPOs
- HashiCorp (2021)
- Udemy (2021)
- KnowBe4 (2021)
- Impel NeuroPharma (2021 —Underwriters Counsel)
- Edgewise Therapeutics (2021)
- Seer (2020)
- Kinnate Biopharma (2020)
- ORIC Pharmaceuticals (2020)
- IGM Biosciences (2019)
- Peloton Therapeutics (2019—sold on eve of IPO)
- Allakos (2018)
- Dropbox (2018)
- Okta (2017—Underwriters Counsel)
- Denali Therapeutics (2017)
Select Public Clients
- Block (Square)
- Denali Therapeutics
- Edgewise Therapeutics
- Hawaiian Airlines
- IGM Biosciences
- Inspirato
- Kinnate Biopharma
- KnowBe4
- Seer
- Zymeworks
Select Private Clients
- Druva
- Enliven
- onX
- Plaid
- Pinger
Select Publications
- Tony has been interviewed and quoted in numerous business and legal trade media, including Dow Jones/The Wall Street Journal, The Silicon Valley Business Journal, Law360, The Recorder, and The Daily Journal.
Recent Speaking Engagements
- Panelist, “Nasdaq IPO Bootcamp Webinar Series: Achieving Success as a New Public Company,” May 27, 2020
- Panelist, "Forging ahead: What will shape IPOs in 2018?" Nasdaq Entrepreneurial Center, San Francisco, California, February 2018
- Lecturer, "Funding a New Enterprise – IPOs, M&A And Other Exits," Stanford Continuing Studies Class, Stanford, California, January 2016
- Moderator, "An Evening with the Experts: IPO Panel Discussion," National Investor Relations Institute, San Francisco, California, October 2014
- Panelist, "Compensation Trends and Best Practices," Tech America Board Education Event, Portland, Oregon, November 2010 and November 2011
- Lecturer, "Intellectual Property Issues in IPOs, M&A Transactions, and Other Strategic Transactions," Stanford Law School, Stanford, California, January 2011
- Presenter, "Preparing for the IPO," Morgan Stanley's "Going Public 2010" Conference, Menlo Park, California, June 2010
Select Publications
- Tony has been interviewed and quoted in numerous business and legal trade media, including Dow Jones/The Wall Street Journal, The Silicon Valley Business Journal, Law360, The Recorder, and The Daily Journal.
Recent Speaking Engagements
- Panelist, “Nasdaq IPO Bootcamp Webinar Series: Achieving Success as a New Public Company,” May 27, 2020
- Panelist, "Forging ahead: What will shape IPOs in 2018?" Nasdaq Entrepreneurial Center, San Francisco, California, February 2018
- Lecturer, "Funding a New Enterprise – IPOs, M&A And Other Exits," Stanford Continuing Studies Class, Stanford, California, January 2016
- Moderator, "An Evening with the Experts: IPO Panel Discussion," National Investor Relations Institute, San Francisco, California, October 2014
- Panelist, "Compensation Trends and Best Practices," Tech America Board Education Event, Portland, Oregon, November 2010 and November 2011
- Lecturer, "Intellectual Property Issues in IPOs, M&A Transactions, and Other Strategic Transactions," Stanford Law School, Stanford, California, January 2011
- Presenter, "Preparing for the IPO," Morgan Stanley's "Going Public 2010" Conference, Menlo Park, California, June 2010
- Privacy Policy
- Terms of Use
- Accessibility